- Home
- ACON vs ORIS Comparison
ACON vs ORIS Comparison
Compare ACON & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACON | ORIS |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Farming/Seeds/Milling |
| Sector | Technology | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4M | 4.6M |
| IPO Year | 2022 | 2024 |
Fundamental Metrics
Financial Performance| Metric | ACON | ORIS |
|---|---|---|
| Price | $5.82 | $0.10 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | 66.3K | ★ 2.0M |
| Earning Date | 11-12-2025 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | $67,483.00 | ★ $12,317,000.00 |
| Revenue This Year | $145.39 | N/A |
| Revenue Next Year | $145.45 | N/A |
| P/E Ratio | ★ N/A | $271.51 |
| Revenue Growth | ★ 36.91 | N/A |
| 52 Week Low | $5.55 | $0.08 |
| 52 Week High | $3,499.49 | $2.85 |
Technical Indicators
Market Signals| Indicator | ACON | ORIS |
|---|---|---|
| Relative Strength Index (RSI) | 42.43 | 35.70 |
| Support Level | $5.75 | $0.10 |
| Resistance Level | $6.89 | $0.11 |
| Average True Range (ATR) | 0.62 | 0.01 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 7.14 | 3.17 |
Price Performance
Historical ComparisonAbout ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).